An immunological overview of allergen specific immunotherapy — subcutaneous and sublingual routes

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 5, 2009, Pages 253-262

  Ozdemir, Cevdet ^a  

^a MARMARA UNIVERSITY   (Turkey)

Author keywords

allergy; asthma; atopy; regulatory T cell sublingual immunotherapy; subcutaneous immunotherapy

Indexed keywords

ALLERGEN; CD4 ANTIGEN; CORTICOSTEROID; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G4; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 13; INTERLEUKIN 2; INTERLEUKIN 2 RECEPTOR ALPHA; INTERLEUKIN 4; INTERLEUKIN 5; INTERLEUKIN 9; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; PLACEBO; T LYMPHOCYTE RECEPTOR;

ALLERGIC RHINITIS; ALLERGY; ANTIBODY RESPONSE; ANTIGEN PRESENTATION; ASTHMA; ATOPIC DERMATITIS; B LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CELL COUNT; CELL INTERACTION; CELL SUBPOPULATION; CELLULAR IMMUNITY; CLINICAL TRIAL; CYTOKINE PRODUCTION; DENDRITIC CELL; DISEASE COURSE; DRUG EFFICACY; DRUG SAFETY; DRUG TARGETING; HOUSE DUST ALLERGY; HUMAN; IMMUNE RESPONSE; IMMUNOLOGICAL TOLERANCE; IMMUNOPATHOLOGY; IMMUNOREGULATION; IMMUNOTHERAPY; INSECT ALLERGY; MEDICAL DECISION MAKING; PATIENT COMPLIANCE; POLLEN ALLERGY; PRIORITY JOURNAL; REGULATORY T LYMPHOCYTE; REVIEW; RHINOCONJUNCTIVITIS; SYMPTOM; T LYMPHOCYTE; TH1 CELL; TH2 CELL;

ADMINISTRATION, SUBLINGUAL; ASTHMA; DESENSITIZATION, IMMUNOLOGIC; HUMANS; HYPERSENSITIVITY; INJECTIONS, SUBCUTANEOUS;

EID: 70449901330     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809349522     Document Type: Review

References (99)

1. Abramson, M.J., Puy, R.M. and Weiner, J.M. (2003) Allergen immunotherapy for asthma. Cochrane Database Syst Rev: CD001186.
2. Acquistapace, F., Agostinis, F., Castella, V., Kantar, A., Novembre, E., Perrone, M.R. et al. (2009) Efficacy of sublingual specific immunotherapy in intermittent and persistent allergic rhinitis in children: an observational case-control study on 171 patients. The EFESO-children Multicenter Trial. Pediatr Allergy Immunol Mar 23 [Epub ahead of print].
3. Akdis, C.A. (2008) New insights into mechanisms of immunoregulation in 2007. J Allergy Clin Immunol 122: 700-709.
4. Akdis, C.A. and Akdis, M. (2009) Mechanisms and treatment of allergic disease in the big picture of regulatory T cells. J Allergy Clin Immunol 123: 735-746, quiz 747-738.
5. Akdis, C.A., Barlan, I.B., Bahceciler, N. and Akdis, M. (2006) Immunological mechanisms of sublingual immunotherapy. Allergy 61 Suppl 81: 11-14.
6. Akdis, C.A., Blesken, T., Akdis, M., Wuthrich, B. and Blaser, K. (1998) Role of interleukin 10 in specific immunotherapy. J Clin Invest 102: 98-106.
7. Akdis, M. (2006) Healthy immune response to allergens: T regulatory cells and more. Curr Opin Immunol 18: 738-744.
8. Akdis, M. (2008a) Immunologic responses to sublingual allergen immunotherapy. Clin Allergy Immunol 21: 71-86.
9. Akdis, M. (2008b) T-cell tolerance to inhaled allergens: mechanisms and therapeutic approaches. Expert Opin Biol Ther 8: 769-777.
10. Akdis, M. and Akdis, C.A. (2007) Mechanisms of allergen-specific immunotherapy. J Allergy Clin Immunol 119: 780-791.
11. Akpinarli, A., Tuncer, A., Saraclar, Y., Sekerel, B.E. and Kalayci, O. (1999) Effect of formoterol on clinical parameters and lung functions in patients with bronchial asthma: a randomised controlled trial. Arch Dis Child 81: 45-48.
12. Allam, J.P., Novak, N., Fuchs, C., Asen, S., Berge, S., Appel, T. et al. (2003) Characterization of dendritic cells from human oral mucosa: a new Langerhans’ cell type with high constitutive FcepsilonRI expression. J Allergy Clin Immunol 112: 141-148.
13. Allam, J.P., Stojanovski, G., Friedrichs, N., Peng, W., Bieber, T., Wenzel, J. et al. (2008) Distribution of Langerhans cells and mast cells within the human oral mucosa: new application sites of allergens in sublingual immunotherapy? Allergy 63: 720-727.
14. Alpan, O. (2001) Oral tolerance and gut-oriented immune response to dietary proteins. Curr Allergy Asthma Rep 1: 572-577.
15. Alpan, O., Rudomen, G. and Matzinger, P. (2001) The role of dendritic cells, B cells, and M cells in gut-oriented immune responses. J Immunol 166: 4843-4852.
16. Bagnasco, M., Mariani, G., Passalacqua, G., Motta, C., Bartolomei, M., Falagiani, P. et al. (1997) Absorption and distribution kinetics of the major parietaria judaica allergen (Par J 1) administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 100: 122-129.
17. Bahceciler, N.N., Ozdemir, C. and Barlan, I.B. (2007) Immunologic aspects of sublingual immunotherapy in the treatment of allergy and asthma. Curr Med Chem 14: 265-269.
18. Bohle, B., Kinaciyan, T., Gerstmayr, M., Radakovics, A., Jahn-Schmid, B. and Ebner, C. (2007) Sublingual immunotherapy induces Il-10-producing T regulatory cells, allergen-specific T-cell tolerance, and immune deviation. J Allergy Clin Immunol 120: 707-713.
19. Bousquet, J., Lockey, R. and Malling, H.J. (1998) Allergen immunotherapy: therapeutic vaccines for allergic diseases. A WHO position paper. J Allergy Clin Immunol 102: 558-562.
20. Bousquet, J., Scheinmann, P., Guinnepain, M.T., Perrin-Fayolle, M., Sauvaget, J., Tonnel, A.B. et al. (1999) Sublingual-swallow immunotherapy (SLIT) in patients with asthma due to house-dust mites: a double-blind, placebo-controlled study. Allergy 54: 249-260.
21. Bousquet, J., Van Cauwenberge, P. and Khaltaev, N. (2001) Allergic rhinitis and its impact on asthma. J Allergy Clin Immunol 108: S147-334.
22. Burastero, S.E., Mistrello, G., Falagiani, P., Paolucci, C., Breda, D., Roncarolo, D. et al. (2008) Effect of sublingual immunotherapy with grass monomeric allergoid on allergen-specific T-Cell proliferation and interleukin 10 production. Ann Allergy Asthma Immunol 100: 343-350.
23. Burgler, S., Ouaked, N., Bassin, C., Basinski, T.M., Mantel, P.Y., Siegmund, K. et al. (2009) Differentiation and functional analysis of human T(H)17 cells. J Allergy Clin Immunol 123: 588-595, 595 e581-587.
24. Calamita, Z., Saconato, H., Pela, A.B. and Atallah, A.N. (2006) Efficacy of sublingual immunotherapy in asthma: systematic review of randomized-clinical trials using the Cochrane Collaboration method. Allergy 61: 1162-1172.
25. Canonica, G.W. and Passalacqua, G. (2006) Sublingual immunotherapy in the treatment of adult allergic rhinitis patients. Allergy 61(Suppl. 81): 20-23.
26. Chen, W., Jin, W., Hardegen, N., Lei, K.J., Li, L., Marinos, N. et al. (2003) Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor FoxP3. J Exp Med 198: 1875-1886.
27. Clavel, R., Bousquet, J. and Andre, C. (1998) Clinical efficacy of sublingual-swallow immunotherapy: a double-blind, placebo-controlled trial of a standardized five-grass-pollen extract in rhinitis. Allergy 53: 493-498.
28. Cosmi, L., Santarlasci, V., Angeli, R., Liotta, F., Maggi, L., Frosali, F. et al. (2006) Sublingual immunotherapy with dermatophagoides monomeric allergoid down-regulates allergen-specific immunoglobulin E and increases both interferon-gamma- and interleukin-10-production. Clin Exp Allergy 36: 261-272.
29. Cox, L. (2008) Sublingual immunotherapy and allergic rhinitis. Curr Allergy Asthma Rep 8: 102-110.
30. Dardalhon, V., Awasthi, A., Kwon, H., Galileos, G., Gao, W., Sobel, R.A. et al. (2008) Il-4 inhibits TGF-beta-induced FoxP3+ T cells and, together with TGF-beta, generates Il-9+ Il-10+ FoxP3(-) effector T cells. Nat Immunol 9: 1347-1355.
31. Des Roches, A., Paradis, L., Menardo, J.L., Bouges, S., Daures, J.P. and Bousquet, J. (1997) Immunotherapy with a standardized dermatophagoides pteronyssinus extract. VI. Specific immunotherapy prevents the onset of new sensitizations in children. J Allergy Clin Immunol 99: 450-453.
32. Di Gioacchino, M., Perrone, A., Petrarca, C., Di Claudio, F., Mistrello, G., Falagiani, P. et al. (2008) Early cytokine modulation after the rapid induction phase of sublingual immunotherapy with mite monomeric allergoids. Int J Immunopathol Pharmacol 21: 969-976.
33. Eberlein-Konig, B., Ullmann, S., Thomas, P. and Przybilla, B. (1995) Tryptase and histamine release due to a sting challenge in bee venom allergic patients treated successfully or unsuccessfully with hyposensitization. Clin Exp Allergy 25: 704-712.
34. Estes, D.M., Hirano, A., Heussler, V.T., Dobbelaere, D.A. and Brown, W.C. (1995) Expression and biological activities of bovine interleukin 4: Effects of recombinant bovine interleukin 4 on T cell proliferation and B cell differentiation and proliferation in vitro. Cell Immunol 163: 268-279.
35. Fenoglio, D., Puppo, F., Cirillo, I., Vizzaccaro, A., Ferrera, A., Tosca, M.A. et al. (2005) Sublingual specific immunotherapy reduces PBMC proliferations. Eur Ann Allergy Clin Immunol 37: 147-151.
36. Frauwirth, K.A. and Thompson, C.B. (2002) Activation and inhibition of lymphocytes by costimulation. J Clin Invest 109: 295-299.
37. Freeman, G.J., Gribben, J.G., Boussiotis, V.A., Ng, J.W., Restivo Jr, V.A., Lombard, L.A. et al. (1993) Cloning of B7-2: A CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 262: 909-911.
38. Friedman, A. (1996) Induction of anergy in Th1 lymphocytes by oral tolerance. importance of antigen dosage and frequency of feeding. Ann N Y Acad Sci 778: 103-110.
39. Immunotherapy decreases antigen-induced eosinophil cell migration into the nasal cavity. J Allergy Clin Immunol 88: 27-32.
40. Garcia, B.E., Sanz, M.L., Gato, J.J., Fernandez, J. and Oehling, A. (1993) IgG4 blocking effect on the release of antigen-specific histamine. J Investig Allergol Clin Immunol 3: 26-33.
41. Gause, W.C., Urban, J.F., Linsley, P. and Lu, P. (1995) Role of B7 Signaling in the Differentiation of naive CD4+ T Cells to effector interleukin-4-producing T helper cells. Immunol Res 14: 176-188.
42. Gillis, S., Ferm, M.M., Ou, W. and Smith, K.A. (1978) T cell growth factor: parameters of production and a quantitative microassay for activity. J Immunol 120: 2027-2032.
43. Huber, S., Schramm, C., Lehr, H.A., Mann, A., Schmitt, S., Becker, C. et al. (2004) Cutting edge: TGF-beta signaling is required for the in vivo expansion and immunosuppressive capacity of regulatory CD4+CD25+ T Cells. J Immunol 173: 6526-6531.
44. Ippoliti, F., De Santis, W., Volterrani, A., Lenti, L., Canitano, N., Lucarelli, S. et al. (2003) Immunomodulation during sublingual therapy in allergic children. Pediatr Allergy Immunol 14: 216-221.
45. Jutel, M. and Akdis, C.A. (2008) T-cell regulatory mechanisms in specific immunotherapy. Chem Immunol Allergy 94: 158-177.
46. Jutel, M., Akdis, M., Budak, F., Aebischer-Casaulta, C., Wrzyszcz, M., Blaser, K. et al. (2003) Il-10 and TGF-beta cooperate in the regulatory T cell response to mucosal allergens in normal immunity and specific immunotherapy. Eur J Immunol 33: 1205-1214.
47. Jutel, M., Muller, U.R., Fricker, M., Rihs, S., Pichler, W.J. and Dahinden, C. (1996) Influence of bee venom immunotherapy on degranulation and leukotriene generation in human blood basophils. Clin Exp Allergy 26: 1112-1118.
48. Kapsenberg, M.L. (2003) Dendritic-cell control of pathogen-driven T-cell polarization. Nat Rev Immunol 3: 984-993.
49. Kasaian, M.T. and Miller, D.K. (2008) Il-13 as a therapeutic target for respiratory disease. Biochem Pharmacol 76: 147-155.
50. Korn, T., Oukka, M., Kuchroo, V. and Bettelli, E. (2007) Th17 cells: effector T cells with inflammatory properties. Semin Immunol 19: 362-371.
51. Kuo, C.H., Wang, W.L., Chu, Y.T., Lee, M.S. and Hung, C.H. (2009) Sublingual immunotherapy in children: an updated review. Pediatr Neonatol 50: 44-49.
52. Kussebi, F., Karamloo, F., Rhyner, C., Schmid-Grendelmeier, P., Salagianni, M., Mannhart, C. et al. (2005) A major allergen gene-fusion protein for potential usage in allergen-specific immunotherapy. J Allergy Clin Immunol 115: 323-329.
53. Larche, M., Akdis, C.A. and Valenta, R. (2006) Immunological mechanisms of allergen-specific immunotherapy. Nat Rev Immunol 6: 761-771.
54. Lombardi, C., Incorvaia, C., Braga, M., Senna, G., Canonica, G.W. and Passalacqua, G. (2009) Administration regimens for sublingual immunotherapy to pollen allergens: what do we know? Allergy 64: 849-854.
55. Lotvall, J. (2004) Combination therapy in asthma - fixed or variable dosing in different patients? Curr Med Res Opin 20: 1711-1727.
56. Mantel, P.Y., Kuipers, H., Boyman, O., Rhyner, C., Ouaked, N., Ruckert, B. et al. (2007) Gata3-driven Th2 responses inhibit TGF-beta1-induced FoxP3 expression and the formation of regulatory T cells. PLoS Biol 5: e329.
57. Marcucci, F., Incorvaia, C., Sensi, L., Di Cara, G., Cadario, G., Cavaliere, A. et al. (2008) Lack of inflammatory cells in the oral mucosa of subjects undergoing sublingual immunotherapy. Int J Immunopathol Pharmacol 21: 609-613.
58. Marogna, M., Tomassetti, D., Bernasconi, A., Colombo, F., Massolo, A., Businco, A.D. et al. (2008) Preventive effects of sublingual immunotherapy in childhood: an open randomized controlled study. Ann Allergy Asthma Immunol 101: 206-211.
59. Mascarell, L., Lombardi, V., Louise, A., Saint-Lu, N., Chabre, H., Moussu, H. et al. (2008) Oral dendritic cells mediate antigen-specific tolerance by stimulating Th1 and regulatory CD4+ T cells. J Allergy Clin Immunol 122: 603-609e605.
60. Meiler, F., Klunker, S., Zimmermann, M., Akdis, C.A. and Akdis, M. (2008) Distinct regulation of IgE, IgG4 and IgA by T regulatory cells and toll-like receptors. Allergy 63: 1455-1463.
61. Meiler, F., Zumkehr, J., Klunker, S., Ruckert, B., Akdis, C.A. and Akdis, M. (2008) In vivo switch to Il-10-secreting T regulatory cells in high dose allergen exposure. J Exp Med 205: 2887-2898.
62. Moingeon, P., Batard, T., Fadel, R., Frati, F., Sieber, J. and Van Overtvelt, L. (2006) Immune mechanisms of allergen-specific sublingual immunotherapy. Allergy 61: 151-165.
63. Moller, C., Dreborg, S., Ferdousi, H.A., Halken, S., Host, A., Jacobsen, L. et al. (2002) Pollen immunotherapy reduces the development of asthma in children with seasonal rhinoconjunctivitis (the PAT-study). J Allergy Clin Immunol 109: 251-256.
64. Mothes, N., Heinzkill, M., Drachenberg, K.J., Sperr, W.R., Krauth, M.T., Majlesi, Y. et al. (2003) Allergen-specific immunotherapy with a monophosphoryl lipid a-adjuvanted vaccine: reduced seasonally boosted immunoglobulin E production and inhibition of basophil histamine release by therapy-induced blocking antibodies. Clin Exp Allergy 33: 1198-1208.
65. Muller, U., Helbling, A. and Bischof, M. (1989) Predictive value of venom-specific IgE, IgG and IgG subclass antibodies in patients on immunotherapy with honey bee venom. Allergy 44: 412-418.
66. Nelson, H.S. (2005) Advances in upper airway diseases and allergen immunotherapy. J Allergy Clin Immunol 115: 676-684.
67. Novembre, E., Galli, E., Landi, F., Caffarelli, C., Pifferi, M., De Marco, E. et al. (2004) Coseasonal sublingual immunotherapy reduces the development of asthma in children with allergic rhinoconjunctivitis. J Allergy Clin Immunol 114: 851-857.
68. Ouaked, N., Mantel, P.Y., Bassin, C., Burgler, S., Siegmund, K., Akdis, C.A. et al. (2009) Regulation of the FoxP3 gene by the Th1 cytokines: the role of Il-27-induced STAT1. J Immunol 182: 1041-1049.
69. Ozdemir, C., Akdis, M. and Akdis, C.A. (2009) T regulatory cells and their counterparts: masters of immune regulation. Clin Exp Allergy 39: 626-639.
70. Ozdemir, C., Yazi, D., Gocmen, I., Yesil, O., Aydogan, M., Semic-Jusufagic, A. et al. (2007) Efficacy of long-term sublingual immunotherapy as an adjunct to pharmacotherapy in house dust mite-allergic children with asthma. Pediatr Allergy Immunol 18: 508-515.
71. Pajno, G.B., Caminiti, L., Vita, D., Barberio, G., Salzano, G., Lombardo, F. et al. (2007) Sublingual immunotherapy in mite-sensitized children with atopic dermatitis: a randomized, double-blind, placebo-controlled study. J Allergy Clin Immunol 120: 164-170.
72. Passalacqua, G., Albano, M., Fregonese, L., Riccio, A., Pronzato, C., Mela, G.S. et al. (1998) Randomised controlled trial of local allergoid immunotherapy on allergic inflammation in mite-induced rhinoconjunctivitis. Lancet 351: 629-632.
73. Passalacqua, G., Albano, M., Riccio, A., Fregonese, L., Puccinelli, P., Parmiani, S. et al. (1999) Clinical and immunologic effects of a rush sublingual immunotherapy to parietaria species: a double-blind, placebo-controlled trial. J Allergy Clin Immunol 104: 964-968.
74. Passalacqua, G. and Durham, S.R. (2007) Allergic rhinitis and its impact on asthma update: allergen immunotherapy. J Allergy Clin Immunol 119: 881-891.
75. Passalacqua, G., Guerra, L., Compalati, E. and Canonica, G.W. (2007) The safety of allergen specific sublingual immunotherapy. Curr Drug Saf 2: 117-123.
76. Penagos, M., Passalacqua, G., Compalati, E., Baena-Cagnani, C.E., Orozco, S., Pedroza, A. et al. (2008) Metaanalysis of the efficacy of sublingual immunotherapy in the treatment of allergic asthma in pediatric patients, 3 to 18 years of age. Chest 133: 599-609.
77. Razafindratsita, A., Saint-Lu, N., Mascarell, L., Berjont, N., Bardon, T., Betbeder, D. et al. (2007) Improvement of sublingual immunotherapy efficacy with a mucoadhesive allergen formulation. J Allergy Clin Immunol 120: 278-285.
78. Read, S., Malmstrom, V. and Powrie, F. (2000) Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J Exp Med 192: 295-302.
79. Romagnani, S. (2004) Immunologic influences on allergy and the Th1/Th2 balance. J Allergy Clin Immunol 113: 395-400.
80. Romani, N., Koide, S., Crowley, M., Witmer-Pack, M., Livingstone, A.M., Fathman, C.G. et al. (1989) Presentation of exogenous protein antigens by dendritic cells to T cell clones. intact protein is presented best by immature, epidermal Langerhans cells. J Exp Med 169: 1169-1178.
81. Rossi, R.E., Monasterolo, G., Coco, G., Silvestro, L. and Operti, D. (2007) Evaluation of serum IgG4 antibodies specific to grass pollen allergen components in the follow up of allergic patients undergoing subcutaneous and sublingual immunotherapy. Vaccine 25: 957-964.
82. Saint-Lu, N., Tourdot, S., Razafindratsita, A., Mascarell, L., Berjont, N., Chabre, H. et al. (2009) Targeting the allergen to oral dendritic cells with mucoadhesive chitosan particles enhances tolerance induction. Allergy 64: 1003-1013.
83. Sander, I., Fleischer, C., Meurer, U., Bruning, T. and Raulf-Heimsoth, M. (2009) Allergen content of grass pollen preparations for skin prick testing and sublingual immunotherapy. Allergy Apr 6 [Epub ahead of print].
84. Savolainen, J., Jacobsen, L. and Valovirta, E. (2006) Sublingual immunotherapy in children modulates allergen-induced in vitro expression of cytokine mRNA in PBMC. Allergy 61: 1184-1190.
85. Sehmi, R., Wardlaw, A.J., Cromwell, O., Kurihara, K., Waltmann, P. and Kay, A.B. (1992) Interleukin-5 selectively enhances the chemotactic response of eosinophils obtained from normal but not eosinophilic subjects. Blood 79: 2952-2959.
86. Sennhauser, F.H., Braun-Fahrlander, C. and Wildhaber, J.H. (2005) The burden of asthma in children: a European perspective. Paediatr Respir Rev 6: 2-7.
87. Steinman, R.M. and Cohn, Z.A. (1973) Identification of a novel cell type in peripheral lymphoid organs of mice. I. Morphology, quantitation, tissue distribution. J Exp Med 137: 1142-1162.
88. Storms, W.W. (2004) Pharmacologic approaches to daytime and nighttime symptoms of allergic rhinitis. J Allergy Clin Immunol 114: S146-153.
89. Tari, M.G., Mancino, M., Madonna, F., Buzzoni, L. and Parmiani, S. (1994) Immunologic evaluation of 24 month course of sublingual immunotherapy. Allergol Immunopathol (Madr) 22: 209-216.
90. Till, S.J., Francis, J.N., Nouri-Aria, K. and Durham, S.R. (2004) Mechanisms of immuno-therapy. J Allergy Clin Immunol 113: 1025-1034, quiz 1035.
91. Tseng, S.H., Fu, L.S., Nong, B.R., Weng, J.D. and Shyur, S.D. (2008) Changes in serum specific IgG4 and IgG4/IgE ratio in mite-sensitized Taiwanese children with allergic rhinitis receiving short-term sublingual-swallow immunotherapy: a multicenter, randomized, placebo-controlled trial. Asian Pac J Allergy Immunol 26: 105-112.
92. Van Neerven, R.J., Arvidsson, M., Ipsen, H., Sparholt, S.H., Rak, S. and Wurtzen, P.A. (2004) A double-blind, placebo-controlled birch allergy vaccination study: inhibition of CD23-mediated serum-immunoglobulin E-facilitated allergen presentation. Clin Exp Allergy 34: 420-428.
93. Van Neerven, R.J., Wikborg, T., Lund, G., Jacobsen, B., Brinch-Nielsen, A., Arnved, J. et al. (1999) Blocking antibodies induced by specific allergy vaccination prevent the activation of CD4+ T cells by inhibiting serum-IgE-facilitated allergen presentation. J Immunol 163: 2944-2952.
94. Van Wijk, R.G. (2008) When to initiate immunotherapy in children with allergic disease? Lessons from the paediatric studies. Curr Opin Allergy Clin Immunol 8: 565-570.
95. Veldhoen, M., Uyttenhove, C., Van Snick, J., Helmby, H., Westendorf, A., Buer, J. et al. (2008) Transforming growth factor-beta ‘reprograms’ the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat Immunol 9: 1341-1346.
96. Wills-Karp, M. (2004) Interleukin-13 in asthma pathogenesis. Immunol Rev 202: 175-190.
97. Wills-Karp, M., Luyimbazi, J., Xu, X., Schofield, B., Neben, T.Y., Karp, C.L. et al. (1998) Interleukin-13: central mediator of allergic asthma. Science 282: 2258-2261.
98. Wilson, D.R., Irani, A.M., Walker, S.M., Jacobson, M.R., Mackay, I.S., Schwartz, L.B. et al. (2001) Grass pollen immunotherapy inhibits seasonal increases in basophils and eosinophils in the nasal epithelium. Clin Exp Allergy 31: 1705-1713.
99. Yoshinaga, S.K., Whoriskey, J.S., Khare, S.D., Sarmiento, U., Guo, J., Horan, T. et al. (1999) T-cell co-stimulation through B7RP-1 and ICOS. Nature 402: 827-832.